Conservative Treatment of Peripheral Neuropathy and Neuropathic Pain

Clinics in Podiatric Medicine and Surgery

Volumn 23, Issue 3, 2006, Pages 509-530

  Francis, David A ^a   Christopher, Anne T ^b   Beasley, Bradley D ^c  

^a Green Country Podiatry Center   (United States)

^b Pain Evaluation and Treatment Center   (United States)

^c Metro Tulsa Foot and Ankle Specialists   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ARGININE; BENFOTIAMINE; CAPSAICIN; CLONIDINE; DOXEPIN; DULOXETINE; GABAPENTIN; INOSITOL; ISOCARD; ISOSORBIDE DINITRATE; KETAMINE; LEVACECARNINE; LIDOCAINE; MAGNESIUM; MENTHOL; MEXILETINE; NORTRIPTYLINE; OMEGA CONOTOXIN MVIIA; PHENYTOIN; PRASTERONE; PREGABALIN; PRILOCAINE; PRIMROSE OIL; SUCCINIC ACID; TAURINE; THIOCTIC ACID; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE; VITAMIN;

ALLODYNIA; ARTHRITIS; ATAXIA; BLURRED VISION; BURNING SENSATION; CLINICAL TRIAL; DIABETIC NEUROPATHY; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG SAFETY; ERECTILE DYSFUNCTION; FAINTNESS; FATIGUE; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL DISEASE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PALPITATION; HUMAN; HYPOGLYCEMIA; META ANALYSIS; NERVE DECOMPRESSION; NEUROPATHIC PAIN; NONHUMAN; ORTHOSTATIC HYPOTENSION; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; WEIGHT GAIN; XEROSTOMIA;

DIABETIC NEUROPATHIES; HUMANS; NEURALGIA; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 33745699832     PISSN: 08918422     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpm.2006.04.004     Document Type: Review

References (70)

1. Carter G.T., and Galer B.S. Advances in the management of neuropathic pain. Phys Med Rehabil Clin N Am 12 (2001) 447-459
2. Dyck P.J., Kratz K.M., Karnes J.L., et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort. Neurology 43 (1993) 817-824
3. Brooks P.J., and Francisco G.E. Drug therapy of diabetic neuropathy. Clin Pod Med Surg 9 2 (1992) 257-274
4. Armstrong D.G., Lavery L.A., and Harkless L.B. Validation of a diabetic wound classification system: the contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 21 (1998) 855-859
5. Low P., and Dotson R. Symptom treatment of painful neuropathy. JAMA 280 (1998) 1863-1864
6. National diabetes fact sheet, 2005. Available at: http://www.diabetes.org/uedocuments/NationalDiabetesFactSheetRev.pdf. Accessed May 2005.
7. Misha-Miroslav B., and Serra J. Pharmacologic management part I: better-studied neuropathic pain diseases. Pain Med 5 S1 (2004) S28-S47
8. Podwall D., and Gooch C. Diabetic neuropathy: clinical features, etiology and therapy. Curr Neurol Neurosci Rep 4 (2004) 55-61
9. Shaw J.E., and Zimmet P.Z. The epidemiology of diabetic neuropathy. Diabetes Rev 7 (1999) 245-252
10. Maizels M., and McCarberg B. Antidepressants and antiepileptic drugs for chronic non-cancer pain. Am Fam Physician 71 3 (2005) 483-490
11. Sindrup S.H., Bach F.W., Madsen C., et al. Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial. Neurology 60 (2003) 1284-1289
12. Watson C.P., Vernich L., Chipman M., et al. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 51 4 (1998) 1166-1171
13. th Annual Meeting of the American Psychiatric Association. SanFrancisco, May 17-22, 2003.
14. th Annual meeting of the American Academy of Neurology. SanFrancisco, April 24-May 1, 2004.
15. rd Annual Scientific Meeting of the American Pain Society. Vancouver, May 6-9, 2004.
16. Bymaster F.P., Dreshfield-Ahmad L.J., Threlkeld P.G., et al. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacol 25 6 (2001) 871-880
17. Waitekus A.B., and Kirkpatrick P. Duloxetine hydrocloride. Nat Rev Drug Discov 3 11 (2004) 907-908
18. Rosenstock J., Tuchman M., LaMoreaux L., et al. Pregabalin for the treatment of diabetic peripheral neuropathy: a double -blind, placebo-controlled trial. Pain 110 3 (2004) 628-638
19. Sharma U., Allen R., Glessner C., et al. Pregabalin effectively relieves pain in patients with diabetic peripheral neuropathy. Diabetes 49 Suppl 1 (2000) A167
20. Lesser H., Sharma U., LaMoreaux L., et al. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 63 11 (2004) 2104-2110
21. Dworkin R.H., Corbin A.E., Young J.P., et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 60 (2003) 1274-1283
22. Sabatowski R., Galvez R., and Cherry D.A. Pregabalin reduces pain and improves sleep and mood disturbance in patients with post-herpetic neuralgia: results of a randomized, placebo-controlled clinical trial. Pain 109 (2004) 26-35
23. In: Weiner R.S. (Ed). Pain management: a practical guide for clinicians. 6th edition (2002), CRC Press, Boca Raton (FL)
24. Duhmke R.M., Cornblath D.D., and Hollingshead J.R. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2 (2004) CD003726
25. Sindrup S.H., Andersen G., Madsen C., et al. Tramadol relieves pain and allodynia in polyneuropathy: a randomized, double-blind, contolled trial. Pain 83 1 (1999) 85-90
26. Barbano R.L., Herrmann D.N., Hart-Gouleau S., et al. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol June (2004) 914-918
27. Lidoderm prescribing information (2004), Endo Pharmaceuticals Inc, Chadds Ford (PA). Available at: www.lidoderm.com/safety.aspx Accessed April, 2005
28. Jamal G.A. The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy. Diabet Med 11 2 (1994) 145-149
29. Ford I., Cotter M.A., Cameron N.E., et al. The effects of treatment with alpha-lipoic acid or evening primrose oil on vascular hemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocin-diabetic rat. Metabolism 50 8 (2001) 868-875
30. Anonymous. Acetyl-L-carnitine. [letter]. Altern Med Rev 4 6 (1999) 438-441
31. De Grandis D., and Minardi C. Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomized, double-blind, placebo-controlled study. Drugs R D 3 4 (2002) 223-231
32. Sima A.A., Calvani M., Mehra M., et al. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care 28 1 (2005) 89-94
33. Nicklander K.K., McPheee B.R., Low P.A., et al. Alpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy. Free Radic Biol Med 21 5 (1996) 631-639
34. Packer L., Kraemer K., and Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17 10 (2001) 888-895
35. Ametov A.S., Barinov A., Dyck P.J., et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 26 3 (2003) 770-776
36. Reljanovic M., Reichel G., Rett K., et al. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radic Res 31 3 (1999) 171-179
37. Obrosova I.G., Fathallah L., and Stevens M.J. Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy. Exp Neurol 172 1 (2001) 211-219
38. Li F., Obrosova I.G., Abatan O., et al. Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. Am J Physiol Endocrinol Metab 288 1 (2005) E29-E36
39. Ambrosch A., Dierkes J., Lobmann R., et al. Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus. Diabet Med 18 (2001) 185-192
40. Willems F.F., et al. Pharmocokinetic study on the utilisation of 5-methyltetrahudrofolate and folic acid in patients with coronary artery disease. BMJ 141 (2004) 825-830
41. Mauskop A., and Altura B.M. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci 5 1 (1998) 24-27
42. Sima A.A., Dunlap J., Davidson E., et al. Supplemental myo-inositol prevents L-fucose induced diabetic neuropathy. Diabetes 46 2 (1997) 306
43. Olin V.I., Belikova T.V., and Pushkova E.S. Diabetes mellitus in the elderly: succinic acid compounds in treating diabetic neuropathies. Adv Gerontol 9 (2002) 83-87 [in Russian]
44. Yorek M.A., Coppey L.J., Gellett J.S., et al. Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function. Am J Physiol Endocrinol Metab 283 5 (2002) E1067-E1075
45. Witte M.B., and Barbul A. Role of nitric oxide in wound repair. Am J Surg 183 4 (2002) 406-412
46. Stracke H., Hammes H.P., Werkmann D., et al. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats. Exp Clin Endocrinol Diabetes 109 6 (2001) 330-336
47. Haupt E., Ledermann H., and Kopcke W. Benfotiamine in the treatment of diabetic poly neuropathy-a three-week randomized, controlled pilot study (BEDIP study). Int J Clin Pharmacol Ther 43 2 (2005) 71-77
48. Transdermal gel pain management. Available at: http://www.pinepharmacy.com/pain_management_md.asp#gel. Accessed April 21, 2005.
49. nd edition. Vol. 1 (2002), W.B. Saunders, Philadelphia p. 452-4
50. Galeotti N. Menthol: a natural analgesic compound. Neurosci Lett 322 3 (2002) 145-148
51. McCleane G. Doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: double-blind, placebo-controlled study. Br J Pharmacol 49 6 (2000) 574-579
52. Pitei D.L., Watkins P.J., and Edmonds M.E. No-dependent smooth muscle vasodilation is reduced in NIDDM patients with peripheral sensory neuropathy. Diabet Med 14 (1997) 284-290
53. Yuen K.C.J., Baker N.R., and Rayman G. Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray. Diabetes Care 25 10 (2002) 1699-1703
54. Cameron N.E., Cotter M.A., Ferguson K., et al. Angiotensin converting enzyme inhibition prevents the development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats. Diabetologia 35 (1992) 12-18 [abstract]
55. Rayman G., Baker N.R., and Krishnan S.T. Glyceryl trinitrate patches as an alternative to isosorbide dinitrate spray in the treatment of chronic painful diabetic neuropathy. Diabetes Care 26 9 (2003) 2697-2698
56. Lynch M.E., Clark A.J., and Sawynok J. A pilot study examining topical amytriptylene, ketamine, and a combination of both in treatment of neuropathic pain. Clin J Pain 19 (2003) 323-328
57. Milch R.A. Neuropathic pain: implications for the surgeon. Surg Clin N Am 85 2 (2005) 225-236
58. Pray W.S. Consult your pharmacist-shingles: a rising threat with age. US Pharmacist 22 8 (1997)
59. Clonidine hydrochloride. Mosby's Drug Consult [Password protected]. Available at: http://home.mdconsult.com/das/drug/body/367875243/1/846.html. Accessed May 17, 2005.
60. Goldberg N. Monochromatic infrared photo energy and DPN Diab. Microvasc Complications Today March/April (2005) 30-32
61. Burke T.J. Questions and answers about MIRE treatment. Adv Skin Wound Care 16 (2003) 369-371
62. Kochman A.B., Carnegie D.H., and Burke T.J. Symptomatic reversal of peripheral neuropathy in patients with diabetes. JAPMA 92 (2002) 125
63. Leonard D.R., Farooqi H.M., and Myers S. Restoration of sensation, reduced pain, and improved balance in subjects with diabetic peripheral neuropathy. Diabetes Care 27 (2004) 168-172
64. Prendergast J.J., Miranda G., and Sanchez M. Reduced sensory impairment in patients with peripheral neuropathy. Endocr Pract 10 (2004) 24-30
65. DeLellis S.L., Carnegie D.H., and Burke T.J. Improved sensitivity in patients with peripheral neuropathy effects of monochromatic infrared photo energy. JAPMA 95 2 (2005) 143-147
66. Horwitz L.R., Burke T.J., and Carnegie D. Augmentation of wound healing using monochromatic infrared energy exploration of a new technology for wound management. Adv Wound Care 12 (1999) 35-40
67. Thomasson T.L. Effects of skin-contact monochromatic infrared irradiation on tendonitis, capsulitis, and myofascial pain. J Neuro Orthop Med Surg 16 (1996) 242-245
68. Weintraub M.I. Magnetic bio-stimulation in painful diabetic peripheral neuropathy: an novel intervention a randomized, double-placebo, crossover study. Am J Pain Managet 9 (1999) 8-17
69. Biddinger K.R., and Amend M.A. The role of surgical decompression for diabetic neuropathy. Foot Ankle Clin N Am 9 (2004) 239-254
70. Dellon A.L. Diabetic neuropathy: review of a surgical approach to restore sensation, relieve pain, and prevent ulceration and amputation. Foot Ankle Int 25 10 (2004) 749-755